HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris].

AbstractUNLABELLED:
Only few drugs for uncomplicated Plasmodium falciparum malaria are available in children. Atovaquone-proguanil is a recent antimalarial drug licensed in France for the uncomplicated P. falciparum malaria in adults. Few paediatric studies have evaluated atovaquone-proguanil in children for uncomplicated malaria in endemic area, but no study have evaluated this treatment for imported malaria.
OBJECTIVE:
To evaluate treatment by atovaquone-proguanil for uncomplicated and imported P. falciparum malaria in children.
METHODS:
We retrospectively evaluated the tolerance and the efficacy of atovaquone-proguanil in the children admitted in Robert-Debré Hospital (Paris) for a P. falciparum malaria. From January 2004 to December 2005, 48 children with a median age of 7,5 years (IQR 4-11) were treated with atovaquone-proguanil for a uncomplicated P. falciparum malaria, except for 5 children who had an isolated hyperparasitemia greater or equal to 5%.
RESULTS:
Atovaquone-proguanil was stopped for 3/48 children because of vomiting. Fever resolved in all the children between Day 3 and 7, following the beginning of the treatment. One child, with a favourable outcome, had a positive parasitemia at Day 4 equal to the initial parasitemia (0,1%). No late therapeutic failure was observed among the 24 children evaluated up to one month after starting treatment.
CONCLUSION:
Atovaquone-proguanil is an efficient and well-tolerated antimalarial treatment for uncomplicated P. falciparum malaria in children. The risk of vomiting should lead to a systematic initial hospitalisation of children treated with atovaquone-proguanil.
AuthorsR Blondé, J Naudin, Z Bigirimana, L Holvoet, O Fenneteau, C Vitoux, O Bourdon, F Angoulvant, M Lorrot, E D'Ortenzio, A Bourrillon, J Le Bras, S Matheron, A Faye
JournalArchives de pediatrie : organe officiel de la Societe francaise de pediatrie (Arch Pediatr) Vol. 15 Issue 3 Pg. 245-52 (Mar 2008) ISSN: 0929-693X [Print] France
Vernacular TitleTolérance et efficacité de l'atovaquone-proguanil dans le traitement du paludisme d'importation àPlasmodium falciparum de l'enfant en France métropolitaine: expérience d'un centre hospitalier parisien.
PMID18321692 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antimalarials
  • Drug Combinations
  • atovaquone, proguanil drug combination
  • C-Reactive Protein
  • Proguanil
  • Atovaquone
Topics
  • Animals
  • Antimalarials (therapeutic use)
  • Atovaquone (therapeutic use)
  • C-Reactive Protein (metabolism)
  • Child
  • Child, Preschool
  • Drug Combinations
  • Drug Therapy, Combination
  • Drug Tolerance
  • Hospitals, University
  • Humans
  • Liver Function Tests
  • Malaria, Falciparum (drug therapy)
  • Paris
  • Plasmodium falciparum
  • Proguanil (therapeutic use)
  • Retrospective Studies
  • Travel

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: